Table 2.
TERT promoter mutations
TERT promoter mutation |
pTa LG (N =28) |
pTa HG (N =31) |
CIS (N =17) |
P |
---|---|---|---|---|
Present (%) | 24/28 (86%) | 21/31 (68%) | 11/17 (65%) | 0.18 |
CIS: Carcinoma in situ; HG: high-grade noninvasive urothelial carcinoma; LG: low-grade noninvasive urothelial carcinoma.